Benjamin Grenier‐Boley

21.7k citations
81 papers · 16.4k · 9 hit papers · h-index 37

Impact in

  • Physiology top 0.1%
    • Alzheimer's disease research and treatments
  • Neurology top 0.2%
    • Neuroinflammation and Neurodegeneration Mechanisms
    • Parkinson's Disease Mechanisms and Treatments

Papers in

Benjamin Grenier‐Boley

76 papers receiving 16.1k citations

Benjamin Grenier‐Boley's Hit Papers

Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease 2022 · 157 citations
1570+5+10Years since publication1k2k3k

Peers

Benjamin Grenier‐Boley
Comparison fields: 5 of 201
  • Physiology 7.7k
  • Neurology 1.8k
  • Psychiatry and Mental health 4.2k
  • Genetics 2.5k
  • Aging 76
Replace Badri Narayan Vardarajan with:
Badri Narayan Vardarajan United States
Olivier Hanon France
Rebecca Sims United Kingdom
Bernadette McGuinness United Kingdom
Michelle K. Lupton United Kingdom
Peter Passmore United Kingdom
Vincent Antoine Chouraki United States
Denise H. Harold United Kingdom
Céline Bellenguez France
Adam Christian Naj United States
Benjamin Grenier‐Boley relative to Badri Narayan Vardarajan United States Badri Narayan Vardarajan's profile →
Citations per field
00.5×1.5×
Badri Narayan Vardarajan · 1×
Citations per year

Countries citing papers authored by Benjamin Grenier‐Boley

Since Specialization
Citations

This map shows the geographic impact of Benjamin Grenier‐Boley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Grenier‐Boley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Grenier‐Boley more than expected).

Fields of papers citing papers by Benjamin Grenier‐Boley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Grenier‐Boley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Grenier‐Boley. The network helps show where Benjamin Grenier‐Boley may publish in the future.

Co-authors

The 25 scholars most cited alongside Benjamin Grenier‐Boley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benjamin Grenier‐Boley Line = papers co-authored together Benjamin Grenier‐Boley links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Hit paper breakdown →
20133486
2
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Hit paper breakdown →
20192140
3
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Hit paper breakdown →
20111664
4
New insights into the genetic etiology of Alzheimer’s disease and related dementias
Hit paper breakdown →
20221531
5
Analysis of shared heritability in common disorders of the brain
Hit paper breakdown →
20181477
6
Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease
Hit paper breakdown →
20141332
7
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Hit paper breakdown →
2017764
8 2017323
9 2013311
10 2015221
11
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
Hit paper breakdown →
2021221
12 2018204
13 2016193
14 2017178
15 2014169
16
Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease
Hit paper breakdown →
2022157
17 2019156
18 2017132
19 2010125
20 2012101

About Benjamin Grenier‐Boley

Benjamin Grenier‐Boley is a scholar working on Physiology, Psychiatry and Mental health, Genetics, Geriatrics and Gerontology and Cellular and Molecular Neuroscience, having authored 81 papers that have together received 16.4k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (58 papers), Dementia and Cognitive Impairment Research (17 papers), Genetic Associations and Epidemiology (12 papers), MicroRNA in disease regulation (2 papers), Frailty in Older Adults (2 papers), Cerebrospinal fluid and hydrocephalus (2 papers), Receptor Mechanisms and Signaling (1 paper) and RNA and protein synthesis mechanisms (1 paper). The work is most often cited by research in Physiology (7.7k citations), Neurology (1.8k citations), Psychiatry and Mental health (4.2k citations), Genetics (2.5k citations) and Aging (76 citations). Benjamin Grenier‐Boley has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Jean‐Charles Lambert, Céline Bellenguez, Philippe Amouyel, Florence Pasquier, Dominique Campion, Alfredo Ramı́rez, Christophe Tzourio, Jean‐François Dartigues, Claudine Berr and Vilmantas Giedraitis. Their work appears in journals such as Alzheimer s & Dementia, Molecular Psychiatry, Nature Genetics, Neurology and Acta Neuropathologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact